Shabbi S. Khan

Partner

Shabbi S. Khan

Partner

Shabbi Khan serves as a co-chair for the Artificial Intelligence (AI), Automation, and Robotics group within Foley & Lardner’s Manufacturing Sector and is a registered patent attorney and member of the Electronics Practice Group within the firm’s Intellectual Property (IP) department.

Shabbi provides strategic advice on all aspects of IP strategy and enforcement, technology transactions, and licenses. His practice has primarily focused on strategic patent portfolio development, counseling, and management including preparation and prosecution of patent applications, patent infringement analysis, and validity analysis primarily in the fields of AI and machine learning, computer software including cloud and SaaS-based technologies, robotics, medical devices, digital therapeutics, and AI in health care. Shabbi’s technical experience and background, together with his patent prosecution and litigation experience, allows him to quickly understand clients’ technology and products, and prepare high-quality, litigation-ready patents that are aligned with their business objectives.

Shabbi’s practice offers deep experience and a specialty in AI and he helps clients navigate AI-related business and legal issues, including counseling on copyright infringement issues stemming from the use and training of AI models and providing guidance on the operational implementation of AI solutions. As part of his AI practice, Shabbi counsels companies on technology agreements, such as master service agreements, joint development and collaboration agreements, vendor agreements, and technology use and service agreements with a specific eye towards AI related issues and data monetization considerations.

Shabbi also performs buy-side IP due diligence during a merger or acquisition or a financing transaction involving venture capital or private equity. Shabbi also advises technology companies undergoing due diligence or preparing for an upcoming transaction.

Representative Experience

  • Advised clients on AI related concerns including the use of generative AI at work
  • Prepared corporate policies relating to the use of AI and prepared checklists and toolkits for companies relating to deployment of AI solutions
  • Conducted legal due diligence for transactions involving an investment in or acquisition of AI technology companies
  • Developed patent portfolios for emerging tech companies in a variety of technical areas including:
  • AI and machine learning
    • Medical devices
    • Enterprise Software Solutions
    • Software-related medical device technologies
    • Biotechnology, including data and image processing, analysis, and learning
    •  Gaming
    •  Robotics
    • Computer engineering, architecture, and networking
    • Internet of Things (IoT), devices, and applications
    • Data management and storage
    • Virtual Reality (VR), Augmented Reality (AR), and Mixed Reality (MR) technologies
    • Security, cryptography and encryption
    • Wireless, mobile, and related telecommunications systems

Presentations and Publications

  • Author, “European Medtech Companies: Why a U.S. Centric Patent Strategy is Essential for Long-Term Success,” Health Care Law Today (November 12, 2024)
21 April 2025 Health Care Law Today

MedTech Round Table: What the Trump Administration Means for Companies and Investors

Foley & Lardner LLP hosted and participated in a MedTech round table of investors and business leaders, including chief executive officers, partners, directors, innovation leads, investment funds managers and partners, and general counsels. There was collective interest in understanding how these MedTech leaders are adjusting to the changing business and regulatory environment under the second Trump administration.
12 November 2024 Health Care Law Today

European Medtech Companies: Why a U.S. Centric Patent Strategy is Essential for Long-Term Success

As European medtech companies look to expand their presence in the U.S. market, understanding the intricacies of U.S. patent law becomes increasingly important.
19 September 2024 Events

Law School for CFOs

We are excited to host this highly regarded event offered in collaboration with the Boston Chapter of the CFO Leadership Council and presented by Foley & Lardner LLP at our Boston office.
12 June 2024 In the News

Foley Attorneys Assess AI, Regulatory Risks in Financial Markets

Foley & Lardner LLP partners James Lundy, Peter Fetzer, Chanley Howell, Shabbi Khan, and associate William McCaughey assess artificial intelligence risks relevant to broker-dealers and investment advisers in their LexisNexis article, “Artificial Intelligence (AI) and the SEC: Present and Future Risks.”
17 July 2024 Events

Boston Health Care AI & Technology Investor Summit

Join Endeavor Venture Funds & Foley & Lardner for an in-person and virtual gathering dedicated to advancing healthcare technology in Boston!
21 March 2024 Events

Critical Legal Issues and Trends Facing the Automotive Industry

In collaboration with SAA, Foley & Lardner will provide an in-depth review of some of the most critical legal issues and trends facing the automotive industry in 2024.